These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

483 related items for PubMed ID: 16391435

  • 1. Quality of life of head and neck cancer patient: validation of the European organization for research and treatment of cancer QLQ-C30 and European organization for research and treatment of cancer QLQ-H&N 35 in Indian patients.
    Chaukar DA, Das AK, Deshpande MS, Pai PS, Pathak KA, Chaturvedi P, Kakade AC, Hawaldar RW, D'Cruz AK.
    Indian J Cancer; 2005; 42(4):178-84. PubMed ID: 16391435
    [Abstract] [Full Text] [Related]

  • 2. The EORTC QLQ-C30 (version 3.0) Quality of Life questionnaire: validation study for Spain with head and neck cancer patients.
    Arraras JI, Arias F, Tejedor M, Pruja E, Marcos M, Martínez E, Valerdi J.
    Psychooncology; 2002; 11(3):249-56. PubMed ID: 12112486
    [Abstract] [Full Text] [Related]

  • 3. Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.
    Park KU.
    Oncology; 2008; 74 Suppl 1():7-12. PubMed ID: 18758191
    [Abstract] [Full Text] [Related]

  • 4. The European Organization for Research and Treatment of Cancer QLQ-C30: an examination into the cultural validity and reliability of the Turkish version of the EORTC QLQ-C30.
    Guzelant A, Goksel T, Ozkok S, Tasbakan S, Aysan T, Bottomley A.
    Eur J Cancer Care (Engl); 2004 May; 13(2):135-44. PubMed ID: 15115469
    [Abstract] [Full Text] [Related]

  • 5. The relationship between observer-based toxicity scoring and patient assessed symptom severity after treatment for head and neck cancer. A correlative cross sectional study of the DAHANCA toxicity scoring system and the EORTC quality of life questionnaires.
    Jensen K, Bonde Jensen A, Grau C.
    Radiother Oncol; 2006 Mar; 78(3):298-305. PubMed ID: 16524633
    [Abstract] [Full Text] [Related]

  • 6. A cross sectional quality of life study of 116 recurrence free head and neck cancer patients. The first use of EORTC H&N35 in Danish.
    Jensen K, Jensen AB, Grau C.
    Acta Oncol; 2006 Mar; 45(1):28-37. PubMed ID: 16464793
    [Abstract] [Full Text] [Related]

  • 7. Validation of the Mexican Spanish version of the EORTC C30 and STO22 questionnaires for the evaluation of health-related quality of life in patients with gastric cancer.
    Oñate-Ocaña LF, Alcántara-Pilar A, Vilar-Compte D, García-Hubard G, Rojas-Castillo E, Alvarado-Aguilar S, Carrillo JF, Blazeby JM, Aiello-Crocifoglio V.
    Ann Surg Oncol; 2009 Jan; 16(1):88-95. PubMed ID: 18979141
    [Abstract] [Full Text] [Related]

  • 8. Validation of the EORTC QLQ-C30 and EORTC QLQ-H&N35 in patients with laryngeal cancer after surgery.
    Singer S, Wollbrück D, Wulke C, Dietz A, Klemm E, Oeken J, Meister EF, Gudziol H, Bindewald J, Schwarz R.
    Head Neck; 2009 Jan; 31(1):64-76. PubMed ID: 18972411
    [Abstract] [Full Text] [Related]

  • 9. Health-related quality-of-life in patients with head-and-neck cancer in Sri Lanka: psychometric properties of the 'Sinhala' version of the EORTC QLQ-H&N35.
    Jayasekara H, Rajapaksa LC, Aaronson NK.
    Psychooncology; 2009 Oct; 18(10):1116-21. PubMed ID: 19142857
    [Abstract] [Full Text] [Related]

  • 10. The EORTC QLQ-CX24 cervical cancer-specific quality of life questionnaire: psychometric properties in a South Asian sample of cervical cancer patients.
    Jayasekara H, Rajapaksa LC, Greimel ER.
    Psychooncology; 2008 Oct; 17(10):1053-7. PubMed ID: 18203241
    [Abstract] [Full Text] [Related]

  • 11. French version of FACT-G: validation and comparison with other cancer-specific instruments.
    Conroy T, Mercier M, Bonneterre J, Luporsi E, Lefebvre JL, Lapeyre M, Puyraveau M, Schraub S.
    Eur J Cancer; 2004 Oct; 40(15):2243-52. PubMed ID: 15454249
    [Abstract] [Full Text] [Related]

  • 12. The European Organization for Research and Treatment of Cancer (EORTC) Quality-of-Life questionnaire cervical cancer module: EORTC QLQ-CX24.
    Greimel ER, Kuljanic Vlasic K, Waldenstrom AC, Duric VM, Jensen PT, Singer S, Chie W, Nordin A, Bjelic Radisic V, Wydra D, European Organization for Research and Treatment of Cancer Quality-of-Life Group.
    Cancer; 2006 Oct 15; 107(8):1812-22. PubMed ID: 16977652
    [Abstract] [Full Text] [Related]

  • 13. [The European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire for Japanese patients with head and neck cancer--the Japanese version of QLQ-H&N35].
    Toth G, Tsukuda M.
    Gan To Kagaku Ryoho; 2004 Mar 15; 31(3):461-7. PubMed ID: 15045963
    [Abstract] [Full Text] [Related]

  • 14. Health-related quality of life in long-term head and neck cancer survivors: a comparison with general population norms.
    Hammerlid E, Taft C.
    Br J Cancer; 2001 Jan 15; 84(2):149-56. PubMed ID: 11161369
    [Abstract] [Full Text] [Related]

  • 15. The European Organization for Research and Treatment of Cancer quality of life questionnaire: translation and reliability study of the Thai version.
    Sirisinha T, Ratanatharathorn V, Jirajarus M, Sirilerttrakul S, Silpakit C, Sirachainan E, Tanvetyanon T.
    J Med Assoc Thai; 2002 Nov 15; 85(11):1210-9. PubMed ID: 12546319
    [Abstract] [Full Text] [Related]

  • 16. Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaires for Arabic-speaking Populations.
    Awad MA, Denic S, El Taji H.
    Ann N Y Acad Sci; 2008 Sep 15; 1138():146-54. PubMed ID: 18837895
    [Abstract] [Full Text] [Related]

  • 17. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer.
    Blazeby JM, Conroy T, Bottomley A, Vickery C, Arraras J, Sezer O, Moore J, Koller M, Turhal NS, Stuart R, Van Cutsem E, D'haese S, Coens C, European Organisation for Research and Treatment of Cancer Gastrointestinal and Quality of Life Groups.
    Eur J Cancer; 2004 Oct 15; 40(15):2260-8. PubMed ID: 15454251
    [Abstract] [Full Text] [Related]

  • 18. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma.
    Cocks K, Cohen D, Wisløff F, Sezer O, Lee S, Hippe E, Gimsing P, Turesson I, Hajek R, Smith A, Graham L, Phillips A, Stead M, Velikova G, Brown J, EORTC Quality of Life Group.
    Eur J Cancer; 2007 Jul 15; 43(11):1670-8. PubMed ID: 17574838
    [Abstract] [Full Text] [Related]

  • 19. Validation of the Mexican Spanish version of the EORTC QLQ-H&N35 instrument to measure health-related quality of life in patients with head and neck cancers.
    Carrillo JF, Ortiz-Toledo MA, Salido-Noriega Z, Romero-Ventura NB, Ochoa-Carrillo FJ, Oñate-Ocaña LF.
    Ann Surg Oncol; 2013 May 15; 20(5):1417-26. PubMed ID: 23108555
    [Abstract] [Full Text] [Related]

  • 20. Validation of EORTC quality-of-life questionnaire in Indian women with operable breast cancer.
    Parmar V, Badwe RA, Hawaldar R, Rayabhattanavar S, Varghese A, Sharma R, Mittra I.
    Natl Med J India; 2005 May 15; 18(4):172-7. PubMed ID: 16252544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.